HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

BC032913 as a Novel Antisense Non-coding RNA is Downregulated in Gastric Cancer.

AbstractBACKGROUND:
Long non-coding RNAs (lncRNAs) are a subset of non-coding RNAs. Abnormal expression of lncRNAs is associated with the development of cancers including gastric cancer (GC). Increasing evidence in this field reveals that lncRNAs have a key role in biological actions via modulating the expression of genes at various genomic levels. BC032913, as a novel antisense lncRNA, may have a role in GC progression.
OBJECTIVE:
The very aim of this study was to examine the clinical significance and the functional role of lncRNA BC032913 in GC.
METHODS:
QRT-PCR technique was exerted to survey the expression level of BC032913 in GC tissues and matched adjacent non-tumorous tissues. Furthermore, the association between clinicopathological parameters and the expression level of BC032913 was evaluated.
RESULTS:
BC032913 expression was downregulated in cancerous tissues as compared with adjacent non-tumorous tissues (P = 0.0108). Downregulation of BC032913 expression did not demonstrate a significant association with clinicopathological parameters.
CONCLUSION:
LncRNA BC032913 may be considered as an impressive therapeutic target for GC.
AuthorsShiva Behzadi, Behzad Baradaran, Mohammad Ali Hosseinpourfeizi, Narges Dastmalchi, Ali Rajabi, Milad Asadi, Reza Safaralizadeh
JournalJournal of gastrointestinal cancer (J Gastrointest Cancer) Vol. 52 Issue 3 Pg. 928-931 (Sep 2021) ISSN: 1941-6636 [Electronic] United States
PMID32914372 (Publication Type: Journal Article)
Copyright© 2020. Springer Science+Business Media, LLC, part of Springer Nature.
Chemical References
  • RNA, Long Noncoding
  • BCO1 protein, human
  • beta-Carotene 15,15'-Monooxygenase
Topics
  • Down-Regulation
  • Humans
  • RNA, Long Noncoding (genetics)
  • Stomach Neoplasms (genetics)
  • beta-Carotene 15,15'-Monooxygenase (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: